Compound Detail
CHEMBL2103851
AMUVATINIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL2103851 |
| Name | AMUVATINIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | FOFDIMHVKGYHRU-UHFFFAOYSA-N |
3
Targets
7
Activities
2
Assay Types
3
PK Parameters
20
Publications
7
Known Names
2
Indications
4
Mechanisms
Molecular Properties
447.5
MW (Da)
3.30
ALogP
7
HBA
1
HBD
75.9
PSA (Ų)
0.48
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase receptor FLT3 inhibitor | INHIBITOR | Receptor-type tyrosine-protein kinase FLT3 | ✓ | ✓ |
| Stem cell growth factor receptor inhibitor | INHIBITOR | Mast/stem cell growth factor receptor Kit | ✓ | ✓ |
| Hepatocyte growth factor receptor inhibitor | INHIBITOR | Hepatocyte growth factor receptor | ✓ | ✓ |
| Platelet-derived growth factor receptor alpha inhibitor | INHIBITOR | Platelet-derived growth factor receptor alpha | ✓ | ✓ |
Indications
Small Cell Lung Carcinoma Neoplasms
Activity Summary
IC50 5 meas. best 7.7
EC50 2 meas. best 4.57
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SARS-CoV-2 CHEMBL4303835 | IC50 | 7.7 | 7.7 | 20.0 | 1 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | IC50 | 5.8 | 5.8 | 1600.0 | 2 |
| Platelet-derived growth factor receptor alpha CHEMBL2007 | IC50 | 5.68 | 5.6 | 2100.0 | 2 |
| Platelet-derived growth factor receptor alpha CHEMBL2007 | EC50 | 4.57 | 4.57 | 27163.0 | 1 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | EC50 | 4.5 | 4.5 | 31257.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 7910.0 | ng.hr.mL-1 | Rattus norvegicus |
| Cmax | 1586.52 | nM | Rattus norvegicus |
| Tmax | 11.3 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 29191878 | 10.1126/science.aan4368 | Actin-related protein 2 | 1 |
| 29191878 | 10.1126/science.aan4368 | Beta-adrenergic receptor kinase 1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Adenosine kinase | 1 |
| 38157838 | 10.1016/j.bmc.2023.117561 | Unchecked | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-2B | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1B | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Actin-related protein 3 | 1 |
| 29191878 | 10.1126/science.aan4368 | Peroxisomal acyl-coenzyme A oxidase 3 | 1 |
| 29191878 | 10.1126/science.aan4368 | Peroxisomal acyl-coenzyme A oxidase 1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 11 | 1 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 10 | 1 |
| 29191878 | 10.1126/science.aan4368 | Tyrosine-protein kinase ABL2 | 1 |
| 29191878 | 10.1126/science.aan4368 | Tyrosine-protein kinase ABL1 | 1 |
Data from ChEMBL 36 via Core Engine